Company · CIK 1439725
BIODESIX INC
| CIK | 1439725 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 8071 — Services-Medical Laboratories |
| Incorporated in | DE |
| Business address | CO |
| Listed | BDSX (Nasdaq) |
| First annual or quarterly report | 2020-12-10 |
Offerings
7 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-296122 | 2026-05-21 | 2026-05-29 | 2 | |
| 333-282938 | 2024-11-01 | 2024-11-12 | 3 | |
| 333-282939 | 2024-11-01 | 2024-11-12 | 2 | |
| 333-261095 | 2021-11-16 | 2024-08-07 | 9 | |
| 333-278881 | 2024-04-23 | 2024-06-04 | 3 | |
| 333-265448 | 2022-06-06 | 2022-06-17 | 2 | |
| 333-249260 | 2020-10-02 | 2020-10-29 | 7 |
Filings
29| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-05-29 | EFFECTDeclared effective | 333-296122 | 9999999995-26-001816 |
| 2026-05-21 | S-3Shelf registered | 333-296122 | 0001193125-26-234611 |
| 2024-11-12 | EFFECTDeclared effective | 333-282939 | 9999999995-24-003463 |
| 2024-11-12 | EFFECTDeclared effective | 333-282938 | 9999999995-24-003462 |
| 2024-11-12 | 424B5Shelf takedown | 333-282938 | 0001193125-24-255988 |
| 2024-11-01 | S-3Shelf registered | 333-282939 | 0001193125-24-249183 |
| 2024-11-01 | S-3Shelf registered | 333-282938 | 0001193125-24-249180 |
| 2024-08-07 | 424B5Shelf takedown | 333-261095 | 0001193125-24-195940 |
| 2024-06-04 | EFFECTDeclared effective | 333-278881 | 9999999995-24-001736 |
| 2024-05-24 | S-1/AAmendment | 333-278881 | 0001193125-24-147047 |
| 2024-04-23 | S-1Registration filed | 333-278881 | 0001193125-24-107051 |
| 2024-04-05 | 424B5Shelf takedown | 333-261095 | 0001193125-24-087953 |
| 2024-04-05 | 424B5Shelf takedown | 333-261095 | 0001193125-24-087858 |
| 2022-11-18 | 424B5Shelf takedown | 333-261095 | 0001193125-22-288966 |
| 2022-11-16 | 424B5Shelf takedown | 333-261095 | 0001193125-22-286754 |
| 2022-06-17 | EFFECTDeclared effective | 333-265448 | 9999999995-22-001817 |
| 2022-06-06 | S-3Shelf registered | 333-265448 | 0001193125-22-168484 |
| 2022-03-07 | 424B5Shelf takedown | 333-261095 | 0001193125-22-067944 |
| 2021-12-22 | 424B5Shelf takedown | 333-261095 | 0001193125-21-364989 |
| 2021-11-29 | EFFECTDeclared effective | 333-261095 | 9999999995-21-004502 |
| 2021-11-16 | S-3Shelf registered | 333-261095 | 0001193125-21-330437 |
| 2020-10-29 | 424B4Final prospectus | 333-249260 | 0001193125-20-281042 |
| 2020-10-27 | EFFECTDeclared effective | 333-249260 | 9999999995-20-002996 |
| 2020-10-26 | S-1/AAmendment | 333-249260 | 0001193125-20-275630 |
| 2020-10-21 | S-1/AAmendment | 333-249260 | 0001193125-20-273369 |
| 2020-10-14 | S-1/AAmendment | 333-249260 | 0001193125-20-268763 |
| 2020-10-09 | S-1/AAmendment | 333-249260 | 0001193125-20-266992 |
| 2020-10-02 | S-1Registration filed | 333-249260 | 0001193125-20-262422 |
| 2020-08-12 | DRSDraft made public | 377-03408 | 0000950123-20-008365 |